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Two new  ﬂavonoids  (1 and  2), named  4′,7-dihydroxy-5-hydroxymethyl-8-prenylﬂavonoid  and  4′,7-
dihydroxy-5-hydroxymethyl-6,8-diprenylﬂavonoid,  together  with  seven  known  ﬂavonoids  (3–9)  were
isolated from  the aerial  parts  of  Capsella  bursa-pastoris  (L.)  Medik.,  Brassicaceae,  for  the  ﬁrst  time.  The






references.  Moreover,  compounds  (1–9) were  evaluated  for their  hepatoprotective  activities  against
d-galactosamine  induced  toxicity  in WB-F344  cells  by using  a  MTT  colorimetric  method.  As  a result,
compounds  2, 3, 6, and 9  (10 M)  exhibited  moderate  hepatoprotective  activities.
© 2016  Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  This  is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).epatoprotective activity
ntroduction
Capsella bursa-pastoris (L.) Medik. is an annual or biennial herb
elonging to the Brassicaceae family, and used as a popular veg-
table in Chinese folk. Meanwhile, C. bursa-pastoris has always
een served for a medicinal plant to threat conjunctivitis, vomit,
etrorrhagia, and hydropsy (Wang et al., 2014). Diverse groups
f biological activities are reported to be present in the differ-
nt plant parts of C. bursa-pastoris which possessed anti-tumor
Kelko et al., 1976), anti-inﬂammatory (Yue et al., 2007), anti-
xidant (Zhang et al., 2008), anti-microbial (Yang et al., 2010),
nd anti-hypertensive (Huang et al., 2005) activities. Previous
hytochemical investigations of C. bursa-pastoris exhibited the
resence of amino acids (Xu et al., 2004a,b), ﬂavonoids (Song et al.,
009), alkaloids (Pan, 2006), and essential oils (Gao and Zhou,
009).
After consulting a large number of references, we  found that
here have few reports on hepatoprotective activities of C. bursa-
astoris, which prompted us to study its hepatoprotective effect.
e carried out a bioassay-guided investigation of C. bursa-pastoris
n order to evaluate its hepatoprotective activity. As a result,
ine compounds (1–9), including two new compounds, named
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E-mails: maqinge2006@163.com (Q. Ma), weirongrui2011@163.co (R. Wei).
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102-695X/© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Edit
reativecommons.org/licenses/by-nc-nd/4.0/).4′,7-dihydroxy-5-hydroxymethyl-8-prenylﬂavonoid (1) and 4′,7-
dihydroxy-5-hydroxymethyl-6,8-diprenylﬂavonoid (2), were iso-
lated and identiﬁed from the active fractions (EtOAc fraction) of C.
bursa-pastoris.  The known compounds (3–9) were obtained from
C. bursa-pastoris for the ﬁrst time. All the compounds (1–9) were
evaluated for their hepatoprotective activities, which were tested
against d-galactosamine induced toxicity in WB-F344 cells by using
the MTT  colorimetric method (Ma et al., 2014).
Materials and methods
Plant material
Capsella bursa-pastoris (L.) Medik., Brassicaceae, was harvested
from Nanyang, Henan province, China, in March 2014. This plant
was identiﬁed by Dr. Su Zhang of Wuyang Weisen Biological
Medicine Co., Ltd,. A voucher specimen (No. JC-201403) has been
deposited in Nanyang Normal University.
Extraction and isolation
The dried aerial parts of C. bursa-pastoris (11 kg) were extracted
with 70% EtOH (17 l ×3) three times, each time for 30 min. The
extract was  concentrated by rotary evaporator under reduced
pressure resulting in a black extractum (1.1 kg). The combined
extracts were successively partitioned with petroleum ether,
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tOAc, and n-butanol to yield three parts: petroleum ether extract
108.5 g), EtOAc extract (237 g), and n-butanol extract (320.7 g). It
as found that the EtOAc extract exhibited potential hepatoprotec-
ive activity according to bioassay-guided investigation. Therefore,
he EtOAc part was subjected to column chromatography (sil-
ca gel, 100–200 mesh) and eluted with a solvent of petroleum
ther/EtOAc (10:1, 6:1, 3:1, 1:1, 1:2) to obtain ﬁve fractions: A
28.4 g), B (33.6 g), C (48.1 g), D (40.4 g), and E (47.5 g), respec-
ively.
The fraction B was  fractionated on column chromatogra-
hy (silica gel, 200–300 mesh) and eluted with petroleum
ther/EtOAc (9:1 → 6:1 → 4:1, v/v) to obtain three sub-fractions:
-a, B-b, B-c, separately. The separation of B-b (9.05 g) was chro-
atographed on silica gel (100–200 mesh, 200–300 mesh) and
ephadex LH-20, repeatedly, yielded 3 (11.56 mg), 6 (9.68 mg),
nd 9 (10.21 mg). Similarly, the fraction C was applied to a silica
el CC and eluted with petroleum ether/EtOAc (5:1 → 3:1 → 1:1,
/v) to give three sub-fractions: C-a, C-b, C-c, separately. These
ub-fractions were chromatographed over Sephadex LH-20 and
ilica gel CC (100–200, 200–300 mesh) eluting with suitable
obile phases, yielded 1 (8.05 mg), 2 (9.32 mg), 5 (11.36 mg), and
 (13.20 mg). The fraction D was separately puriﬁed by MPLC
30–100% MeOH–H2O), silica gel (200–300 mesh), and Sephadex
H-20 (MeOH in H2O, 95%), and yielded 4 (9.55 mg)  and 8
12.25 mg).
4′,7-dihydroxy-5-hydroxymethyl-8-prenylﬂavonoid (1):  pale
ellow powder; mp  131.5–132.8 ◦C; UV (MeOH) max: 206,
55, 288, and 337 nm;  IR max 3429.8, 2952.4, 1657.8, 1608.5,
357.4, and 1004.2 cm−1; 1H and 13C NMR  spectroscopic data see
able 1; HR-ESI-MS: m/z  375.6853 [M+Na]+ (calcd. for C21H20O5Na,
75.6851).
4′,7-dihydroxy-5-hydroxymethyl-6,8-diprenylﬂavonoid (2):
ale yellow powder; mp  135.1–136.7 ◦C; UV (MeOH) max: 206,
58, 286, and 335 nm;  IR max 3430.3, 2950.7, 1657.2, 1605.8,
359.1, and 1003.6 cm−1; 1H and 13C NMR  spectroscopic data see
able 1; HR-ESI-MS: m/z  443.1562 [M+Na]+ (calcd for C26H28O5Na
43.1568).
able 1
H NMR  (400 MHz, DMSO-d6), 13C NMR  (100 MHz, DMSO-d6) and key HMBC correlations
No. 1 
ıH ıC HMBC 
1 – – – 
2  – 164.5 – 
3  6.75(s) 104.2 C-4 
4  – 180.2 – 
4a  – 112.2 – 
5  – 142.6 – 
5-CH2 4.58(s) 46.2 C-4a,C-6 
6  6.78(s) 108.1 C-8 
7  – 162.0 – 
8  – 111.8 – 
8a  – 158.6 – 
1′ – 123.1 – 
2′ 7.85(d,8.5) 128.6 C-2,C-4′
3′ 6.86(d,8.5) 115.7 – 
4′ – 157.5 – 
5′ 6.86(d,8.5) 115.7 – 
6′ 7.85(d,8.5) 128.6 C-1,C-4′
1′′ 3.48(d,6.6) 22.8 C-8a, C-3′′′
2′′ 5.20(t,6.6,3.0) 122.7 C-8 
3′′ – 132.0 – 
4′′-CH3 1.65(s) 25.1 – 
5′′-CH3 1.71(s) 18.6 – 
1′′′ – – – 
2′′′ – – – 
3′′′ – – – 
4′′′-CH3 – – – 
5′′′-CH3 – – – acognosia 26 (2016) 710–713 711
General experimental procedures
The UV and IR spectra were measured by Australia GBC UV-
916 spectrophotometer and Nicolet 5700 FT-IR spectrometer
with KBr pellets, separately. The melting points were mea-
sured on WRX-4 microscopic melting point apparatus (Shanghai
Suoguang Electric Technlogy Co., Ltd, China) which was uncor-
rected. The 1D & 2D NMR  spectral data were run on Bruker-400
with TMS  as internal standard (Ma  et al., 2015). The HR-ESI-
MS data were measured by Agilent 1100 series LC/MSD ion
trap mass spectrometer. MPLC was  carried out on a BUCHI
Sepacore spectrometer with DAD detector (BUCHI Labortech-
nik AG, Switzerland) (Ma  et al., 2013). Column chromatography
was performed on silica gel (100–200, 200–300) mesh (Qing-
dao Yuminyuan Silica-Gel Reagent Factory, Qingdao, China), and
Sephadex LH-20 (Amersham Pharmacia Biotech Co., Ltd., Tokyo,
Japan).
Hepatoprotective assay
The hepatoprotective activities of compounds (1–9)
were evaluated for using a 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) colorimetric assay in
WB-F344 rat hepatic epithelial stem-like cells according to
the procedure described previously (Feng et al., 2013; Xu et al.,
2004a,b). The WB-F344 cell lines were fostered with 3% fetal calf
serum, penicillin (100 units/ml), and 100 units/ml streptomycin
in 5% CO2 at 37 ◦C in Dulbecco’s modiﬁed eagle medium (DMEM).
They were put the 96-well microplate and precultured for 24 h. The
fresh medium (200 l) containing bicyclol and test samples were
added and the cells were cultured for 1 h (Hsiao et al., 2013). The
cultured cells were measured for cytotoxic effects which exposed
to 40 mM d-galactosamine for 24 h. The medium was  replaced for
the serum-free medium (0.5 mg/ml  MTT) for 3.5 h incubation. After
removing of the medium and adding DMSO (150 l/well) into the
microplate, the formazan crystals were redissolved. At last, the
optical density (OD) was measured at 492 nm by a microplate










































































Hepatoprotective effects of selective compounds against d-galactosamine-induced
toxicity in WB-F344 cells.a




Normal 100.0 ± 7.3 –
Control 32.2 ± 2.1 –
Bicyclolb 53.4 ± 6.5c 31.3
2  63.7 ± 8.2c 46.5
3  49.9 ± 4.6d 26.1
6  51.9 ± 4.1d 29.1
9  61.2 ± 5.7c 42.8
a Results were expressed as means ± SD (n = 3; for normal and control, n = 6).
b Positive control substance.12 Q. Ma et al. / Revista Brasileira d
eader. Therefore, the inhibition was calculated by the following









Compound 1 was obtained as a pale yellow powder, and its
olecular formula was deduced to be C21H20O5 by HR-ESI-MS
ata at m/z  375.6853 [M+Na]+ (calcd. for C21H20O5Na, 375.6851),
mplying twelve degrees of unsaturation. Its UV spectrum showed
he absorptions at max 206, 255, 288, and 337 nm,  which indi-
ated the absorption peaks characteristic of the 8-prenylﬂavone
keleton (Hossain and Rahman, 2015). The IR absorptions indicated
he existence of hydroxyl (3429.8 cm−1), carbonyl (1657.8 cm−1),
romatic ring (1608.5 cm−1), methyl (1357.4 cm−1) functional
roups.
The 1H NMR  spectrum of compound 1 showed an AA′BB′ system
t ıH 7.85 (2H, d, J = 8.5 Hz, H-2′, H-6′), 6.86 (2H, d, J = 8.5 Hz, H-3′,
-5′), and two singlet signals at ıH 6.75 (1H, s, H-3), 6.78 (1H, s,
-6) in the aromatic region, combined with 15 aromatic carbons in
he 13C NMR  spectrum implied the existence of the ﬂavone struc-
ure (Table 1). A typical singlet ıH 4.58 (2H, s, 5-CH2) was  observed
n the high ﬁeld of 1H NMR  spectrum, which indicated a hydroxy-
ethyl group (Chen et al., 2015) was in compound 1. Moreover,
 group complex signals at ıH 3.48 (2H, d, J = 6.6 Hz, H-1′′), 5.20
1H, t, J = 6.6, 3.0 Hz, H-2′′), 1.65 (3H, s, 4′′-CH3), 1.71 (3H, s, 5′′-
H3) were shown in the 1H NMR  spectrum, which suggested the
resence of a prenyl group in compound 1. The structure of 1 was
stablished on the HMBC correlations of H-3/C-4; 5-CH2/C-4a, C-6;
-6/C-8; H-2′/C-2, C-4′; H-6′/C-2, C-4′; H-1′′/C-8a, C-3′′; H-2′′/C-8
Fig. 1) and the 1H–1H COSY correlations of H-2′/H-3′; H-5′/H-6′;
-1′′/H-2′′ (Fig. 1). Therefore, compound 1 was elucidated as 4′,7-
ihydroxy-5-hydroxymethyl-8-prenylﬂavonoid.
Compound 2 was isolated as a pale yellow powder. Its molec-
lar formula was  determined to be C26H28O5 by HR-ESI-MS: m/z
43.1562 [M+Na]+ (calcd. for C26H28O5Na 443.1568). According to
he spectral data of UV (MeOH) max: 206, 258, 286, 335 nm and IR
max 3430.3, 2950.7, 1657.2, 1605.8, 1359.1, 1003.6 cm−1, we  con-
luded that compound 2 was an analog of compound 1 (Hossain
nd Rahman, 2015).
Compared with the 1H NMR  and 13C NMR  spectral data of com-
ound 1, it was concluded that the spectral data of compound 2
ere closely comparable to those of compound 1 (Table 1). The
nly difference was the presence of two prenyl groups: ıH 3.50
2H, d, J = 6.6 Hz, H-1′′), 5.21 (1H, t, J = 6.6, 3.0 Hz, H-2′′), 1.66 (3H, s,
′′-CH3), 1.73 (3H, s, 5′′-CH3); ıH 3.48 (2H, d, J = 6.9 Hz, H-1′′′), 5.19






















Fig. 1. Key HMBC (H → C) and 1H–1H COSY correlations of compounds 1–2.c p < 0.05, signiﬁcantly different from control by Student′s t-test.
d p < 0.01, signiﬁcantly different from control by Student′s t-test.
in compound 2. Some important correlations of H-3/C-4; 5-CH2/C-
4a, C-6; H-2′/C-2, C-4′; H-6′/C-2, C-4′; H-1′′/C-7, C-3′′; H-1′′′/C-8a,
C-3′ ′′; H-2′ ′′/C-8 in the HMBC spectrum and correlations of H-2′/H-
3′; H-5′/H-6′; H-1′′/H-2′′; H-1′′′/H-2′′′ in the 1H–1H COSY spectrum
were seen in Fig. 1. Therefore, compound 2 was  determined as
4′,7-dihydroxy-5-hydroxymethyl-6,8-diprenylﬂavonoid.
In addition, other seven known compounds (3–9) were
identiﬁed by comparison of their spectroscopic data with
those reported in the literature. Their structures were deter-
mined as chrysoeriol-7-O--d-glucopyranoside (3) (Zhang et al.,
2005), acacetin-7-O--d-glucopyranoside (4) (Zhang et al., 2005),
quercetin (5) (Shabrawy et al., 2014), sinensetin (6) (Hossain and
Rahman, 2015), licoﬂavonol (7) (Kwon et al., 2010), icaritin (8) (Gao
et al., 2013), and 6,8-diprenylgalangin (9) (Jain and Zutshi, 1973).
Furthermore, the known compounds (3–9) were isolated from this
plant for the ﬁrst time.
Hepatoprotective activities
Compounds (1–9) were evaluated for their hepatoprotective
activities against d-galactosamine induced WB-F344 cell damage
with the bicyclol (hepatoprotective activity drug) as the positive
drug (Ma  et al., 2014). The screening results of hepatoprotec-
tive activities were exhibited in Table 2, the inhibition (%) of
compounds 2, 3, 6, and 9 based on the computing formula with
values of 46.5, 26.1, 29.1, and 42.8, respectively. However, com-
pounds 1, 4, 5, 7, and 8 exhibited no hepatoprotective activities
which determined by the screening results of bioactivities. We  con-
cluded that the active compounds contained 2-prenyl, 4-prenyl,
and 5′-OCH3 played positive roles in the mediating their hepato-
protective activities. The study of structure–activity relationship
of the active compounds from C. bursa-pastoris which needed
further research. Furthermore, all the values of the active com-
pounds were expressed as means ± SD of three experiments. The
signiﬁcance of unpaired observations between normal or con-
trol and tested samples was  determined by Student’s t-test (Li
et al., 2006). Differences were considered signiﬁcant at p < 0.05
and p < 0.01 (Lin et al., 2011). Therefore, compounds 2, 3, 6,
and 9 (10 M)  exhibited moderate hepatoprotective activities
(Table 2).
Conclusion
In this work, nine ﬂavonoids (1–9) were isolated and identiﬁed
by their spectral data and references from C. bursa-pastoris.  Among
then, compound (1 and 2) were new 5-hydroxymethyl ﬂavonoids,
and the known compounds (3–9) were obtained from this plant
for the ﬁrst time. Moreover, all the compounds (1–9) were evalu-
ated for their hepatoprotective activities against d-galactosamine









































Zhang, H., Li, G.H., Yang, Y.J., Nan, C.X., 2008. Studies on extraction process and freeQ. Ma  et al. / Revista Brasileira d
ontrol substance. As a result, compounds 2, 3, 6, and 9 (10 M)
xhibited moderate hepatoprotective activities.
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